Literature DB >> 19817555

Genetic signature of adult gliomas and correlation with MRI features.

Maria Grazia Bruzzone1, Marica Eoli, Valeria Cuccarini, Marina Grisoli, Lorella Valletta, Gaetano Finocchiaro.   

Abstract

In recent years the amount of information concerning the genetics and the biology of gliomas, and particularly of glioblastoma multiforme, increased steadily. Such an increase has been paralleled by the technological progress of MRI. The merging of these scientific areas, as summarized in this review, is helping the stratification of glioma patients for clinical trials and their clinical follow-up. Although available therapeutic options appear limited in number, it is likely that in the next 5 years, both as a consequence of the increased knowledge due to genomic sequencing of hundreds of glioblastoma specimens and to continuous improvements of MRI, new perspectives will be available for these patients, with a sizable impact on their prognosis.

Entities:  

Mesh:

Year:  2009        PMID: 19817555     DOI: 10.1586/erm.09.44

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  8 in total

Review 1.  Genetics and imaging of oligodendroglial tumors.

Authors:  Jonathan R Ellenbogen; Carol Walker; Michael D Jenkinson
Journal:  CNS Oncol       Date:  2015-10-19

2.  Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma.

Authors:  J A Carrillo; A Lai; P L Nghiemphu; H J Kim; H S Phillips; S Kharbanda; P Moftakhar; S Lalaezari; W Yong; B M Ellingson; T F Cloughesy; W B Pope
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-09       Impact factor: 3.825

3.  Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images.

Authors:  Kourosh M Naeini; Whitney B Pope; Timothy F Cloughesy; Robert J Harris; Albert Lai; Ascia Eskin; Reshmi Chowdhury; Heidi S Phillips; Phioanh L Nghiemphu; Yalda Behbahanian; Benjamin M Ellingson
Journal:  Neuro Oncol       Date:  2013-02-26       Impact factor: 12.300

Review 4.  Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science.

Authors:  Fred H Hochberg; Nadia A Atai; David Gonda; Michael S Hughes; Brolin Mawejje; Leonora Balaj; Robert S Carter
Journal:  Expert Rev Mol Diagn       Date:  2014-05       Impact factor: 5.225

5.  Potential role of preoperative conventional MRI including diffusion measurements in assessing epidermal growth factor receptor gene amplification status in patients with glioblastoma.

Authors:  R J Young; A Gupta; A D Shah; J J Graber; A D Schweitzer; A Prager; W Shi; Z Zhang; J Huse; A M P Omuro
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-27       Impact factor: 3.825

Review 6.  Use of MRI, metabolomic, and genomic biomarkers to identify mechanisms of chemoresistance in glioma.

Authors:  Cathy W Levenson; Thomas J Morgan; Pamela D Twigg; Timothy M Logan; Victor D Schepkin
Journal:  Cancer Drug Resist       Date:  2019-09-19

Review 7.  Regional Development of Glioblastoma: The Anatomical Conundrum of Cancer Biology and Its Surgical Implication.

Authors:  Ciro De Luca; Assunta Virtuoso; Michele Papa; Francesco Certo; Giuseppe Maria Vincenzo Barbagallo; Roberto Altieri
Journal:  Cells       Date:  2022-04-15       Impact factor: 7.666

8.  Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis.

Authors:  Binghao Zhao; Yuekun Wang; Yaning Wang; Congxin Dai; Yu Wang; Wenbin Ma
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.